These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35339806)

  • 1. Arm lean mass measured using dual-energy X-ray absorptiometry to predict mortality in older patients with heart failure.
    Saito H; Matsue Y; Maeda D; Kamiya K; Kagiyama N; Endo Y; Yoshioka K; Mizukami A; Minamino T
    Arch Gerontol Geriatr; 2022; 101():104689. PubMed ID: 35339806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of muscle mass assessed by dual-energy X-ray absorptiometry and bioelectrical impedance analysis in older patients with heart failure.
    Saito H; Matsue Y; Maeda D; Kasai T; Kagiyama N; Endo Y; Zoda M; Mizukami A; Yoshioka K; Hashimoto T; Ishikawa K; Minamino T
    Geriatr Gerontol Int; 2022 Aug; 22(8):610-615. PubMed ID: 35751442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia prognosis using dual-energy X-ray absorptiometry and prediction model in older patients with heart failure.
    Saito H; Matsue Y; Maeda D; Kagiyama N; Endo Y; Yoshioka K; Mizukami A; Minamino T
    ESC Heart Fail; 2024 Apr; 11(2):914-922. PubMed ID: 38212896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthropometric parameters-derived estimation of muscle mass predicts all-cause mortality in heart failure patients.
    Katano S; Honma S; Nagaoka R; Numazawa R; Yamano K; Fujisawa Y; Ohori K; Kouzu H; Hashimoto A; Katayose M; Yano T
    ESC Heart Fail; 2022 Dec; 9(6):4358-4365. PubMed ID: 36065759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis.
    Eriksen CS; Kimer N; Suetta C; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G729-G740. PubMed ID: 33729006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of upper and lower extremity muscle mass in heart failure.
    Konishi M; Akiyama E; Matsuzawa Y; Sato R; Kikuchi S; Nakahashi H; Okada K; Iwahashi N; Kosuge M; Ebina T; Hibi K; Misumi T; Tamura K; Kimura K
    ESC Heart Fail; 2023 Feb; 10(1):732-737. PubMed ID: 36221798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.
    Sinclair M; Hoermann R; Peterson A; Testro A; Angus PW; Hey P; Chapman B; Gow PJ
    Liver Int; 2019 Jun; 39(6):1089-1097. PubMed ID: 30746903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).
    Dos Santos MR; Saitoh M; Ebner N; Valentova M; Konishi M; Ishida J; Emami A; Springer J; Sandek A; Doehner W; Anker SD; von Haehling S
    J Am Med Dir Assoc; 2017 Mar; 18(3):240-245. PubMed ID: 27816483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary Role of Arm Circumference to Body Mass Index in Risk Stratification in Heart Failure.
    Kamiya K; Masuda T; Matsue Y; Inomata T; Hamazaki N; Matsuzawa R; Tanaka S; Nozaki K; Maekawa E; Noda C; Yamaoka-Tojo M; Matsunaga A; Izumi T; Ako J
    JACC Heart Fail; 2016 Apr; 4(4):265-73. PubMed ID: 26874391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and Prognostic Value of Multidomain Frailty Defined by Cumulative Deficit and Phenotype Models in Patients With Heart Failure.
    Fujimoto Y; Matsue Y; Maeda D; Kagiyama N; Sunayama T; Dotare T; Jujo K; Saito K; Kamiya K; Saito H; Ogasahara Y; Maekawa E; Konishi M; Kitai T; Iwata K; Wada H; Hiki M; Kasai T; Nagamatsu H; Ozawa T; Izawa K; Yamamoto S; Aizawa N; Wakaume K; Oka K; Momomura SI; Minamino T
    Can J Cardiol; 2024 Apr; 40(4):677-684. PubMed ID: 38007218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure.
    Melenovsky V; Kotrc M; Borlaug BA; Marek T; Kovar J; Malek I; Kautzner J
    J Am Coll Cardiol; 2013 Oct; 62(18):1660-1670. PubMed ID: 23916933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of muscle mass assessed by DEXA in elderly hospitalized patients.
    Monereo-Muñoz M; Martín-Ponce E; Hernández-Luis R; Quintero-Platt G; Gómez-Rodríguez-Bethencourt MÁ; González-Reimers E; Santolaria F
    Clin Nutr ESPEN; 2019 Aug; 32():118-124. PubMed ID: 31221276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of muscle and fat mass in patients with heart failure.
    Konishi M; Akiyama E; Matsuzawa Y; Sato R; Kikuchi S; Nakahashi H; Maejima N; Iwahashi N; Kosuge M; Ebina T; Hibi K; Misumi T; von Haehling S; Anker SD; Tamura K; Kimura K
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):568-576. PubMed ID: 33939328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadriceps Strength and Mortality in Older Patients With Heart Failure.
    Nakamura T; Kamiya K; Hamazaki N; Matsuzawa R; Nozaki K; Ichikawa T; Yamashita M; Maekawa E; Reed JL; Noda C; Meguro K; Yamaoka-Tojo M; Matsunaga A; Ako J
    Can J Cardiol; 2021 Mar; 37(3):476-483. PubMed ID: 32622879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of nutritional status in alcoholics, assessed by double-energy X-ray absorptiometry.
    González-Reimers E; García-Valdecasas-Campelo E; Santolaria-Fernández F; Sánchez-Pérez MJ; Rodríguez-Rodríguez E; Gómez-Rodríguez MA; Viña-Rodríguez J
    Alcohol Alcohol; 2008; 43(3):314-9. PubMed ID: 18310599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of adiponectin with peripheral muscle status in elderly patients with heart failure.
    Loncar G; Bozic B; von Haehling S; Düngen HD; Prodanovic N; Lainscak M; Arandjelovic A; Dimkovic S; Radojicic Z; Popovic V
    Eur J Intern Med; 2013 Dec; 24(8):818-23. PubMed ID: 24095654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.